Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 19-12-2018 | Practice Area: | Corporate and M&A |
| Deal Title: | GlaxoSmithKline plc Joint Venture Agreement with Pfizer Inc | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Slaughter and May advised GlaxoSmithKline plc on its agreement with Pfizer Inc. to combine their consumer health businesses into a joint venture with combined sales of approximately GBP9.8 billion. GSK wias to have a majority controlling interest of 68% and Pfizer was to have an equity interest of 32% in the joint venture.
|
||
| Financial Center: | London | Value: | 0.00-0.00 |
| Advised Party: | Joint Venture Party | Law Firm | Slaughter and May |
| JV Party Jurisdiction | United Kingdom | JV Party Jurisdiction | United Kingdom |
| Classification: |
Joint Ventures Continuing Business Partnership |
Lawyer | David Johnson |
